| 1 |
Novel graphene-based biosensor for early detection of Zika virus infection |
https://www.ncbi.nlm.nih.gov/pubmed/28865242 |
Biosensors & bioelectronics |
Afsahi S1, Lerner MB1, Goldstein JM2, Lee J2, Tang X2, Bagarozzi DA Jr2, Pan D1, Locascio L1, Walker A1, Barron F1, Goldsmith BR3. |
| 2 |
Functional RNA during Zika virus infection. |
https://www.ncbi.nlm.nih.gov/pubmed/28864425 |
Virus research |
Göertz GP1, Abbo SR2, Fros JJ3, Pijlman GP4. |
| 3 |
Larvicidal and pupicidal evaluation of silver nanoparticles synthesized using Aquilaria sinensis and Pogostemon cablin essential oils against dengue and zika viruses vector Aedes albopictus mosquito and its histopathological analysis. |
https://www.ncbi.nlm.nih.gov/pubmed/28859534 |
Artificial cells, nanomedicine, and biotechnology |
Ga'al H1,2, Fouad H1,3, Mao G1, Tian J1, Jianchu M1 |
| 4 |
Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV. |
https://www.ncbi.nlm.nih.gov/pubmed/28854372 |
Cell reports |
Rechtien A1, Richert L2, Lorenzo H3, Martrus G4, Hejblum B3, Dahlke C5, Kasonta R5, Zinser M6, Stubbe H7, Matschl U4, Lohse A6, Krähling V8, Eickmann M8, Becker S8; VEBCON Consortium, Thiébaut R3, Altfeld M4, Addo M9 |
| 5 |
Random Forest-Based Evaluation of Raman Spectroscopy for Dengue Fever Analysis |
https://www.ncbi.nlm.nih.gov/pubmed/28862033 |
Applied spectroscopy |
Khan S1, Ullah R1, Khan A2, Sohail A2, Wahab N2, Bilal M1,3, Ahmed M1. |
| 6 |
Dengue virus and Japanese encephalitis virus infection of the central nervous system share similar profiles of cytokine accumulation in cerebrospinal fluid. |
https://www.ncbi.nlm.nih.gov/pubmed/28860941 |
Central-European journal of immunology |
Li H1,2, Li Y1,3,2, Wen B1,2, Zhang J1, Wang C1, Song Z1, Li S1, Qu X1, Huang R1, Liu W1,2 |
| 7 |
Increased adaptive immune responses and proper feedback regulation protect against clinical dengue. |
https://www.ncbi.nlm.nih.gov/pubmed/28855396 |
Science translational medicine |
Simon-Lorière E1,2, Duong V3, Tawfik A1,2, Ung S4, Ly S5, Casadémont I1,2, Prot M1,2, Courtejoie N1,2, Bleakley K6,7, Buchy P3,8, Tarantola A5,8, Dussart P3, Cantaert T9, Sakuntabhai A10,2. |
| 8 |
Community effectiveness of indoor spraying as a dengue vector control method: A systematic review. |
https://www.ncbi.nlm.nih.gov/pubmed/28859087 |
PLoS neglected tropical diseases |
Samuel M1, Maoz D2, Manrique P3, Ward T4, Runge-Ranzinger S5, Toledo J6, Boyce R7, Horstick O1. |
| 9 |
Time course of cellular HIV-DNA and low-level HIV viremia in HIV-HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals |
https://www.ncbi.nlm.nih.gov/pubmed/28864951 |
Medical microbiology and immunology |
Parisi SG1, Andreis S2, Basso M2, Cavinato S3, Scaggiante R3, Franzetti M3, Andreoni M4, Palù G2, Cattelan AM3. |
| 10 |
Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B. |
https://www.ncbi.nlm.nih.gov/pubmed/28865603 |
The Kaohsiung journal of medical sciences |
Tsai JF1, Chen SC2, Lin ZY2, Dai CY2, Huang JF2, Yu ML2, Chuang WL2. |
| 11 |
Cumulative incidence and risk factors for the development of hepatocellular carcinoma in patients with chronic hepatitis B who achieved sustained disappearance of viremia by nucleos(t)ide analogue treatment. |
https://www.ncbi.nlm.nih.gov/pubmed/28865403 |
Hepatology research : the official journal of the Japan Society of Hepatology |
Ando Y1, Ishigami M1, Ishizu Y1, Kuzuya T1, Honda T1, Hayashi K1, Ishikawa T1, Nakano I1, Hirooka Y1, Goto H1. |
| 12 |
The road to a more effective influenza vaccine: Up to date studies and future prospects |
https://www.ncbi.nlm.nih.gov/pubmed/28866292 |
Vaccine |
Sano K1, Ainai A1, Suzuki T1, Hasegawa H2. |
| 13 |
Genetic variation and co-evolutionary relationship of RNA polymerase complex segments in influenza A viruses. |
https://www.ncbi.nlm.nih.gov/pubmed/28866238 |
Virology |
Chen W1, Xu Q1, Zhong Y1, Yu H1, Shu J1, Ma T1, Li Z2. |
| 14 |
Potential Impact of Changes in the Schedule for Primary DTP Immunization as Control Strategy for Pertussis. |
https://www.ncbi.nlm.nih.gov/pubmed/28859017 |
The Pediatric infectious disease journal |
Bergero PE1, Fabricius G, Hozbor DF, Theeten H, Hens N. |
| 15 |
Safety testing of acellular pertussis vaccines: use of animals and 3Rs alternatives |
https://www.ncbi.nlm.nih.gov/pubmed/28857652 |
Human vaccines & immunotherapeutics |
Hoonakker M1, Arciniega J2, Hendriksen C1. |
| 16 |
Generalisability of vaccine effectiveness estimates: an analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA. |
https://www.ncbi.nlm.nih.gov/pubmed/28851801 |
BMJ Open |
Link-Gelles R1, Westreich D2, Aiello AE2, Shang N1, Weber DJ2, Rosen JB3, Motala T4, Mascola L4, Eason J5, Scherzinger K6, Holtzman C7, Reingold AL8, Barnes M9, Petit S10, Farley MM11,12, Harrison LH13, Zansky S14, Thomas A15, Schaffner W16, McGee L1, Whitney CG1, Moore MR1. |
| 17 |
Meningococcal B Vaccine Failure With a Penicillin-Resistant Strain in a Young Adult on Long-Term Eculizumab. |
https://www.ncbi.nlm.nih.gov/pubmed/28864711 |
Pediatrics |
Parikh SR1, Lucidarme J2, Bingham C3, Warwicker P4, Goodship T5, Borrow R2, Ladhani SN6 |
| 18 |
Surface-Enhanced Raman Spectroscopy-Based Sandwich Immunoassays for Multiplexed Detection of Zika and Dengue Viral Biomarkers |
https://www.ncbi.nlm.nih.gov/pubmed/28875696 |
ACS infectious diseases |
Sánchez-Purrà M1, Carré-Camps M2, de Puig H, Bosch I, Gehrke L3, Hamad-Schifferli K1. |
| 19 |
Structure of the Ebola virus envelope protein MPER/TM domain and its interaction with the fusion loop explains their fusion activity. |
https://www.ncbi.nlm.nih.gov/pubmed/28874543 |
Proceedings of the National Academy of Sciences of the United States of America |
Lee J1,2, Nyenhuis DA1,3, Nelson EA1,4, Cafiso DS1,3, White JM1,4, Tamm LK5,2. |
| 20 |
Prospective study of patients with persistent symptoms of dengue in Brazil |
https://www.ncbi.nlm.nih.gov/pubmed/28876417 |
Revista do Instituto de Medicina Tropical de São Paulo |
Teixeira LAS1, Nogueira FPDS1, Nascentes GAN2. |
| 21 |
Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy. |
https://www.ncbi.nlm.nih.gov/pubmed/28871961 |
eLife |
Rabaa MA1,2, Girerd-Chambaz Y3, Duong Thi Hue K1, Vu Tuan T1, Wills B1,2, Bonaparte M4, van der Vliet D3, Langevin E3, Cortes M5, Zambrano B6, Dunod C3, Wartel-Tram A7, Jackson N3, Simmons CP1,2,8. |
| 22 |
Synthesis and structure-activity relationships of carbohydrazides and 1,3,4-oxadiazole derivatives bearing imidazolidine moiety against the yellow fever and dengue vector, Aedes aegypti. |
https://www.ncbi.nlm.nih.gov/pubmed/28869331 |
Pest management science |
Tok F1, Kocyigit-Kaymakcioglu B1, Tabanca N2,3, Estep AS3,4, Gross AD2, Geldenhuys WJ5, Becnel JJ3, Bloomquist JR2. |
| 23 |
Performance of the QuantiFERON-TB Gold Assay Among HIV-infected Children with Active Tuberculosis in France. |
https://www.ncbi.nlm.nih.gov/pubmed/28877156 |
The Pediatric infectious disease journal |
Hormi M1, Khourouj VG, Pommelet V, Jeljeli M, Pédron B, Diana JS, Faye A, Sterkers G. |
| 24 |
A new mouse line for cell ablation by diphtheria toxin subunit A controlled by a Cre-dependent FLEx switch. |
https://www.ncbi.nlm.nih.gov/pubmed/28875587 |
Genesis (New York, N.Y. : 2000) |
Plummer NW1, Ungewitter EK2, Smith KG1, Yao HH2, Jensen P1. |
| 25 |
Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis. |
https://www.ncbi.nlm.nih.gov/pubmed/28877190 |
PloS one |
Vutien P1,2, Jin M1, Le MH1, Nguyen P1, Trinh S1, Huang JF3, Yu ML3, Chuang WL3, Nguyen MH1. |
| 26 |
Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons. |
https://www.ncbi.nlm.nih.gov/pubmed/28877235 |
PloS one |
Monamele GC1,2, Vernet MA1, Njankouo MR1, Victoir K3, Akoachere JF2, Anong D2, Njouom R1. |
| 27 |
Epidemiological and ecological determinants of Zika virus transmission in an urban setting |
https://www.ncbi.nlm.nih.gov/pubmed/28887877 |
eLife |
Lourenço J1, Maia de Lima M2, Faria NR1, Walker A1, Kraemer MU1, Villabona-Arenas CJ3, Lambert B1, Marques de Cerqueira E4, Pybus OG1, Alcantara LC2, Recker M5. |
| 28 |
Cooperation of the Ebola proteins VP40 and GP1,2 with BST2 to activate NF-κβ independently of virus-like particle trapping |
https://www.ncbi.nlm.nih.gov/pubmed/28878074 |
Journal of virology |
Rizk MG1, Basler CF2, Guatelli J3,4. |
| 29 |
Indices of anti-Dengue immunoglobulin G subclasses in adult Mexican patients with febrile and hemorrhagic dengue in the acute phase. |
https://www.ncbi.nlm.nih.gov/pubmed/28881485 |
Microbiology and immunology |
Posadas-Mondragón A1, Aguilar-Faisal JL1, Chávez-Negrete A2, Guillén-Salomón E3, Alcántara-Farfán V4, Luna-Rojas L1, Ávila-Trejo AM1, Del Carmen Pacheco-Yépez J5. |
| 30 |
HLA based selection of epitopes offers a potential window of opportunity for vaccine design against HIV. |
https://www.ncbi.nlm.nih.gov/pubmed/28888341 |
Vaccine |
Sundaramurthi JC1, Ashokkumar M1, Swaminathan S1, Hanna LE2. |
| 31 |
Geographic patterns and environmental factors associated with human yellow fever presence in the Americas. |
https://www.ncbi.nlm.nih.gov/pubmed/28886023 |
PLoS neglected tropical diseases |
Hamrick PN1, Aldighieri S1, Machado G2, Leonel DG1, Vilca LM3, Uriona S3, Schneider MC1 |
| 32 |
Meningococcal B Vaccine Failure With a Penicillin-Resistant Strain in a Young Adult on Long-Term Eculizumab |
https://www.ncbi.nlm.nih.gov/pubmed/28864711 |
Pediatrics |
Parikh SR1, Lucidarme J2, Bingham C3, Warwicker P4, Goodship T5, Borrow R2, Ladhani SN6 |
| 33 |
Serotype and MLST-based inference of population structure of clinical Streptococcus pneumoniae from invasive and noninvasive pneumococcal disease |
https://www.ncbi.nlm.nih.gov/pubmed/28867594 |
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases |
Zhou H1, Guo J2, Qin T1, Ren H3, Xu Y2, Wang C4, Xu X5. |
| 34 |
Validation of the World Health Organization Enzyme-Linked Immunosorbent Assay for the Quantitation of Immunoglobulin G Serotype-Specific Anti-Pneumococcal Antibodies in Human Serum. |
https://www.ncbi.nlm.nih.gov/pubmed/28875600 |
Journal of Korean medical science |
Lee H1,2, Lim SY2, Kim KH2,3 |
| 35 |
Tetanus Toxoid carrier protein induced T-helper cell responses upon vaccination of middle-aged adults. |
https://www.ncbi.nlm.nih.gov/pubmed/28882444 |
Vaccine |
van der Heiden M1, Duizendstra A2, Berbers GAM2, Boots AMH3, Buisman AM4. |
| 36 |
The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26-27 October 2016, Oxford, UK. |
https://www.ncbi.nlm.nih.gov/pubmed/28802757 |
Vaccine |
Meiring JE1, Gibani M2; TyVAC Consortium Meeting Group:. |
| 37 |
Therapeutic drug monitoring of antitubercular agents for disseminated Mycobacterium tuberculosis during intermittent haemodialysis and continuous venovenous haemofiltration. |
https://www.ncbi.nlm.nih.gov/pubmed/28895161 |
Journal of clinical pharmacy and therapeutics |
Sin JH1, Elshaboury RH1, Hurtado RM2, Letourneau AR2, Gandhi RG1. |
| 38 |
Zika virus structural biology and progress in vaccine development. |
https://www.ncbi.nlm.nih.gov/pubmed/28916391 |
Biotechnology advances |
Lin HH1, Yip BS2, Huang LM3, Wu SC4. |
| 39 |
Implementation of a study to examine the persistence of Ebola virus in the body fluids of Ebolavirus disease survivors in Sierra Leone: Methodology and lessons learned. |
https://www.ncbi.nlm.nih.gov/pubmed/28892501 |
PLoS neglected tropical diseases |
Deen GF1, McDonald SLR2, Marrinan JE2, Sesay FR3, Ervin E4, Thorson AE5, Xu W6,7, Ströher U4, Ongpin P8, Abad N9, Ariyarajah A2, Malik T10, Liu H6,7, Ross C11, Durski KN12, Gaillard P2, Morgan O13, Formenty P12, Knust B4, Broutet N5, Sahr F3; Sierra Leone Ebola Virus Persistence Study Group. |
| 40 |
Intrahost Selection Pressures Drive Rapid Dengue Virus Microevolution in Acute Human Infections. |
https://www.ncbi.nlm.nih.gov/pubmed/28910637 |
Cell host & microbe |
Parameswaran P1, Wang C1, Trivedi SB1, Eswarappa M1, Montoya M1, Balmaseda A2, Harris E3. |
| 41 |
Perturbed cholesterol and vesicular trafficking associated with dengue blocking in Wolbachia-infected Aedes aegypti cells. |
https://www.ncbi.nlm.nih.gov/pubmed/28904344 |
Nature communications |
Geoghegan V1,2, Stainton K2,3, Rainey SM1, Ant TH1,2, Dowle AA4, Larson T4, Hester S5, Charles PD5, Thomas B5, Sinkins SP |
| 42 |
Meta-analyses of the proportion of Japanese encephalitis virus infection in vectors and vertebrate hosts. |
https://www.ncbi.nlm.nih.gov/pubmed/28882172 |
Parasites & vectors |
Oliveira ARS1, Cohnstaedt LW2, Strathe E3, Hernández LE1, McVey DS2, Piaggio J4, Cernicchiaro N5. |
| 43 |
Enhanced cytopathic effect of Japanese encephalitis virus strain SA14-14-2: Probable association of mutation in amino acid of its envelope protein. |
https://www.ncbi.nlm.nih.gov/pubmed/28867626 |
Microbial pathogenesis |
Nath B1, Gupta A1, Khan SA2, Kumar S3. |
| 44 |
Envelope glycoprotein mobility on HIV-1 particles depends on the virus maturation state. |
https://www.ncbi.nlm.nih.gov/pubmed/28916807 |
Nature communications |
Chojnacki J1, Waithe D2, Carravilla P3, Huarte N3, Galiani S4, Enderlein J5, Eggeling C6. |
| 45 |
Tetanus, diphtheria, and acellular pertussis vaccination during pregnancy and reduced risk of infant acute respiratory infections. |
https://www.ncbi.nlm.nih.gov/pubmed/28916245 |
Vaccine |
Khodr ZG1, Bukowinski AT2, Gumbs GR2, Conlin AMS2. |
| 46 |
Updated Dosing Instructions for Immune Globulin (Human) GamaSTAN S/D for Hepatitis A Virus Prophylaxis. |
https://www.ncbi.nlm.nih.gov/pubmed/28910270 |
MMWR. Morbidity and mortality weekly report |
Nelson NP1. |
| 47 |
Mapping a Type-specific Epitope by Monoclonal Antibody against VP3 Protein of Duck Hepatitis A Type 1 Virus. |
https://www.ncbi.nlm.nih.gov/pubmed/28883462 |
Scientific reports |
Wu X1, Zhang T1, Meng F1, Guo D1, Yin X1, Wulin S1, Li C1, Zhang Q1, Liu M2, Zhang Y3. |
| 48 |
Evolution of T Cell Responses during Measles Virus Infection and RNA Clearance. |
https://www.ncbi.nlm.nih.gov/pubmed/28904342 |
Scientific reports |
Nelson AN1, Putnam N1,2, Hauer D1, Baxter VK1,3,4, Adams RJ3, Griffin DE5. |
| 49 |
Monitoring hand, foot and mouth disease by combining search engine query data and meteorological factors. |
https://www.ncbi.nlm.nih.gov/pubmed/28898935 |
The Science of the total environment |
Huang DC1, Wang JF2. |
| 50 |
Nasopharyngeal bacterial load as a marker for rapid and easy diagnosis of invasive pneumococcal disease in children from Mozambique. |
https://www.ncbi.nlm.nih.gov/pubmed/28910402 |
PloS one |
Brotons P1,2, Bassat Q3,4,5,6,7, Lanaspa M3,5, Henares D1, Perez-Arguello A1, Madrid L3,5, Balcells R5, Acacio S5, Andres-Franch M1,2, Marcos MA3, Valero-Rello A1,2, Muñoz-Almagro C1,2,8. |
| 51 |
Identification of a Tetanus Toxin Specific Epitope in Single Amino Acid Resolution. |
https://www.ncbi.nlm.nih.gov/pubmed/28922578 |
Biotechnology journal |
Palermo A1, Weber LK1, Rentschler S1, Isse A1, Sedlmayr M1, Herbster K1, List V2, Hubbuch J3, Löffler FF1, Nesterov-Müller A1, Breitling F1 |
| 52 |
Molecular and cellular signatures underlying superior immunity against Bordetella pertussisupon pulmonary vaccination. |
https://www.ncbi.nlm.nih.gov/pubmed/28930286 |
Mucosal immunology |
Raeven RH1,2, Brummelman J3,4, Pennings J5, van der Maas L1, Helm K3, Tilstra W1, van der Ark A1, Sloots A1, van der Ley P1, van Eden W4, Jiskoot W2, van Riet E1, van Els CA3, Kersten GF1,2, Han WG3, Metz B1. |
| 53 |
Safety, Tolerability, and Pharmacokinetics of Radavirsen (AVI-7100), an Antisense Oligonucleotide Targeting Influenza A M1/M2 translation. |
https://www.ncbi.nlm.nih.gov/pubmed/28929521 |
British journal of clinical pharmacology |
Beigel JH1, Voell J2, Muñoz P2, Kumar P3, Brooks KM3, Zhang J4, Iversen P4,5, Heald A4,6, Wong M4,7, Davey RT2. |
| 54 |
Sensitive Genotyping of Foodborne-Associated Human Noroviruses and Hepatitis A Virus Using an Array-Based Platform. |
https://www.ncbi.nlm.nih.gov/pubmed/28930175 |
Sensors (Basel, Switzerland) |
Quiñones B1, Lee BG2, Martinsky TJ3, Yambao JC4, Haje PK5, Schena M6. |
| 55 |
Structure-related roles for the conservation of the HIV-1 fusion peptide sequence revealed by NMR. |
https://www.ncbi.nlm.nih.gov/pubmed/28930470 |
Biochemistry |
Serrano S, Huarte N, Rujas E, Andreu D, Nieva JL, Jimenez MA. |
| 56 |
PERK Signal-Modulated Protein Translation Promotes the Survivability of Dengue 2 Virus-Infected Mosquito Cells and Extends Viral Replication. |
https://www.ncbi.nlm.nih.gov/pubmed/28930151 |
Viruses |
Hou JN1, Chen TH2, Chiang YH3, Peng JY4, Yang TH5, Cheng CC6, Sofiyatun E7,8, Chiu CH9,10, Chiang-Ni C11,12, Chen WJ13, |
| 57 |
Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes. |
https://www.ncbi.nlm.nih.gov/pubmed/28928210 |
mBio |
Andrade DV1, Katzelnick LC1, Widman DG2, Balmaseda A3, de Silva AM4, Baric RS2,4, Harris E5. |
| 58 |
Viral outbreaks involve destabilized evolutionary networks: evidence from Ebola, Influenza and Zika. |
https://www.ncbi.nlm.nih.gov/pubmed/28928377 |
Scientific reports |
Aris-Brosou S1,2, Ibeh N3, Noël J3. |
| 59 |
A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. |
https://www.ncbi.nlm.nih.gov/pubmed/28939807 |
Nature communications |
Shan C1, Muruato AE2, Jagger BW3, Richner J3, Nunes BTD1,4, Medeiros DBA1,4, Xie X1, Nunes JGC1,4, Morabito KM5, Kong WP5, Pierson TC6, Barrett AD7,8,9,10, Weaver SC2,10,11,12, Rossi SL7,8,9, Vasconcelos PFC4,13, Graham BS14, Diamond MS15,16,17,18, Shi PY19,20,21,22,23. |
| 60 |
Global reaction to the recent outbreaks of Zika virus: Insights from a Big Data analysis |
https://www.ncbi.nlm.nih.gov/pubmed/28934352 |
Plos One |
Bragazzi NL1, Alicino C1, Trucchi C1, Paganino C1, Barberis I1, Martini M1, Sticchi L1,2, Trinka E3,4, Brigo F5,6, Ansaldi F1, Icardi G1,2, Orsi A1 |
| 61 |
Viral outbreaks involve destabilized evolutionary networks: evidence from Ebola, Influenza and Zika. |
https://www.ncbi.nlm.nih.gov/pubmed/28928377 |
Scientific reports |
Aris-Brosou S1,2, Ibeh N3, Noël J3. |
| 62 |
Combinatorial peptide-based epitope mapping from Ebola virus DNA vaccines and infections reveals residue-level determinants of antibody binding. |
https://www.ncbi.nlm.nih.gov/pubmed/28922082 |
Human vaccines & immunotherapeutics |
Ripoll DR1, Mitchell DAJ2, Dupuy LC2, Wallqvist A1, Schmaljohn C2, Chaudhury S1. |
| 63 |
A novel immunization approach for dengue infection based on conserved T cell epitopes formulated in calcium phosphate nanoparticles. |
https://www.ncbi.nlm.nih.gov/pubmed/28933657 |
Human vaccines & immunotherapeutics |
Huang X1, Karabudak A1, Comber JD1, Philip M1, Morcol T2, Philip R1. |
| 64 |
PERK Signal-Modulated Protein Translation Promotes the Survivability of Dengue 2 Virus-Infected Mosquito Cells and Extends Viral Replication. |
https://www.ncbi.nlm.nih.gov/pubmed/28930151 |
Virusses |
Hou JN1, Chen TH2, Chiang YH3, Peng JY4, Yang TH5, Cheng CC6, Sofiyatun E7,8, Chiu CH9,10, Chiang-Ni C11,12, Chen WJ13,14,15. |
| 65 |
Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal. |
https://www.ncbi.nlm.nih.gov/pubmed/28934197 |
PLoS neglected tropical diseases |
Upreti SR1, Lindsey NP2, Bohara R3, Choudhary GR3, Shakya S3, Gautam M1, Giri JN3, Fischer M2, Hills SL2. |
| 66 |
Characterization of serum anti-diphtheria antibody activity following administration of equine anti-toxin for suspected diphtheria. |
https://www.ncbi.nlm.nih.gov/pubmed/28933665 |
Human vaccines & immunotherapeutics |
Smith HL1, Saia G1, Lobikin M1, Tiwari T2, Cheng SC3, Molrine DC1. |
| 67 |
Clinically significant mutations in HIV-infected patients with lung adenocarcinoma. |
https://www.ncbi.nlm.nih.gov/pubmed/28934759 |
British journal of cancer |
Thaler J1, Sigel C2, Beasley MB1, Wisnivesky J1, Crothers K3, Bauml J4, Hysell K5, Emu B5, Borsu L2, Sigel K1. |
| 68 |
Crystal structure of an engineered, HIV-specific recombinase for removal of integrated proviral DNA. |
https://www.ncbi.nlm.nih.gov/pubmed/28934476 |
Nucleic acids research |
Meinke G1, Karpinski J2, Buchholz F2,3,4,5, Bohm A1. |
| 69 |
In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication. |
https://www.ncbi.nlm.nih.gov/pubmed/28934369 |
PLoS pathogens |
Marsden MD1, Loy BA2, Wu X3, Ramirez CM4, Schrier AJ2, Murray D5, Shimizu A2, Ryckbosch SM2, Near KE2, Chun TW5, Wender PA2, Zack JA1,3. |
| 70 |
Sensitive Genotyping of Foodborne-Associated Human Noroviruses and Hepatitis A Virus Using an Array-Based Platform. |
https://www.ncbi.nlm.nih.gov/pubmed/28930175 |
Sensors (Basel, Switzerland) |
Quiñones B1, Lee BG2, Martinsky TJ3, Yambao JC4, Haje PK5, Schena M6. |
| 71 |
A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity. |
https://www.ncbi.nlm.nih.gov/pubmed/28934110 |
Virusses |
Julik E1,2, Reyes-Del Valle J3,4. |
| 72 |
Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology. |
https://www.ncbi.nlm.nih.gov/pubmed/28919226 |
Vaccine |
Bohm K1, Filomena A2, Schneiderhan-Marra N2, Krause G3, Sievers C4 |
| 73 |
Economic costs and health-related quality of life for hand, foot and mouth disease (HFMD) patients in China. |
https://www.ncbi.nlm.nih.gov/pubmed/28934232 |
Plos One |
Zheng Y1, Jit M2,3, Wu JT4, Yang J1, Leung K4, Liao Q1, Yu H5. |
| 74 |
Molecular and cellular signatures underlying superior immunity against Bordetella pertussisupon pulmonary vaccination. |
https://www.ncbi.nlm.nih.gov/pubmed/28930286 |
Mucosal immunology |
Raeven RH1,2, Brummelman J3,4, Pennings J5, van der Maas L1, Helm K3, Tilstra W1, van der Ark A1, Sloots A1, van der Ley P1, van Eden W4, Jiskoot W2, van Riet E1, van Els CA3, Kersten GF1,2, Han WG3, Metz B1. |
| 75 |
Geographic patterns and environmental factors associated with human yellow fever presence in the Americas. |
https://www.ncbi.nlm.nih.gov/pubmed/28886023 |
PLoS neglected tropical diseases |
Hamrick PN1, Aldighieri S1, Machado G2, Leonel DG1, Vilca LM3, Uriona S3, Schneider MC1. |
| 76 |
Current Safety Issues with Quadrivalent Meningococcal Conjugate Vaccines |
https://www.ncbi.nlm.nih.gov/pubmed/28934061 |
Human vaccines & immunotherapeutics |
Myers TR1,2, McNeil MM1. |
| 77 |
Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses. |
https://www.ncbi.nlm.nih.gov/pubmed/28945945 |
Advanced healthcare materials |
Schandock F1, Riber CF2, Röcker A1, Müller JA1, Harms M1, Gajda P3, Zuwala K3, Andersen AHF3, Løvschall KB2, Tolstrup M3, Kreppel F1, Münch J1, Zelikin AN2,4. |
| 78 |
Rapid colorimetric detection of Zika virus from serum and urine specimens by reverse transcription loop-mediated isothermal amplification (RT-LAMP). |
https://www.ncbi.nlm.nih.gov/pubmed/28945787 |
Plos One |
Calvert AE1, Biggerstaff BJ1, Tanner NA2, Lauterbach M1, Lanciotti RS1. |
| 79 |
Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection. |
https://www.ncbi.nlm.nih.gov/pubmed/28945244 |
Nature immunology |
Fernandez E1, Dejnirattisai W2, Cao B3, Scheaffer SM3, Supasa P2, Wongwiwat W2, Esakky P3, Drury A3, Mongkolsapaya J2,4, Moley KH3, Mysorekar IU1,3, Screaton GR2,5, Diamond MS1,6,7,8 |
| 80 |
Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8+ T cell response. |
https://www.ncbi.nlm.nih.gov/pubmed/28945243 |
Nature immunology |
Culshaw A1, Ladell K2, Gras S3,4, McLaren JE2, Miners KL2, Farenc C3,4, van den Heuvel H3, Gostick E2, Dejnirattisai W1, Wangteeraprasert A1, Duangchinda T5, Chotiyarnwong P1, Limpitikul W6, Vasanawathana S7, Malasit P8, Dong T9, Rossjohn J2,4, Mongkolsapaya J1,8, Price DA2,10, Screaton GR1. |
| 81 |
Dengue Virus and Its Relation to Human Glycoprotein IIb/IIIa Revealed by Fluorescence Microscopy and Flow Cytometry. |
https://www.ncbi.nlm.nih.gov/pubmed/28945165 |
Viral immunology |
Attatippaholkun N1,2,3,4, U-Pratya Y1,3, Supraditaporn P1, Lorthongpanich C1, Pattanapanyasat K2, Issaragrisil S1,3 |
| 82 |
Mild Encephalitis/Encephalopathy with a Reversible Splenial Lesion in an Adult Patient with Influenza. |
https://www.ncbi.nlm.nih.gov/pubmed/28943565 |
Internal medicine (Tokyo, Japan) |
Takatsu H1, Ishimaru N1, Ito M1, Kinami S1. |
| 83 |
Effects of schistosomiasis on susceptibility to HIV-1 infection and HIV-1 viral load at HIV-1 seroconversion: A nested case-control study. |
https://www.ncbi.nlm.nih.gov/pubmed/28945756 |
PLoS neglected tropical diseases |
Downs JA1,2, Dupnik KM1, van Dam GJ3, Urassa M4, Lutonja P4, Kornelis D3, de Dood CJ5, Hoekstra P3, Kanjala C4, Isingo R4, Peck RN1,2, Lee MH1, Corstjens PLAM5, Todd J6, Changalucha JM4, Johnson WD Jr1, Fitzgerald DW1. |
| 84 |
Resurgence of Pertussis and Emergence of the Ptxp3 Toxin Promoter Allele in South Italy. |
https://www.ncbi.nlm.nih.gov/pubmed/28945679 |
The Pediatric infectious disease journal |
Loconsole D1, De Robertis AL, Morea A, Metallo A, Lopalco PL, Chironna M. |
| 85 |
Preliminary studies on the use of pertussis toxin for the modulation of intravaginal SIV transmission in rhesus macaques |
https://www.ncbi.nlm.nih.gov/pubmed/28940591 |
Journal of medical primatology |
Ortiz K1, Sampathkumar RS2, Ansari AA1, Byrareddy SN2. |
| 86 |
A Streptococcus pneumoniae type 2 oligosaccharide glycoconjugate elicits opsonic antibodies and is protective in an animal model of invasive pneumococcal disease. |
https://www.ncbi.nlm.nih.gov/pubmed/28945368 |
Journal of the American Chemical Society |
Emmadi M, Khan N, Lykke L, Reppe K, G Parameswarappa S, Lisboa MP, Wienhold SM, Witzenrath M, Pereira CL, Seeberger PH. |
